Literature DB >> 18690042

Heterogeneous expression of NO-activated soluble guanylyl cyclase in mammalian heart: implications for NO- and redox-mediated indirect versus direct regulation of cardiac ion channel function.

Mulugu V Brahmajothi1, Donald L Campbell.   

Abstract

Nitrogen oxides exert significant but diverse regulatory effects on cardiac myocytes. Many of these effects are due to modulation of voltage-sensitive ion channel function. The redox-status of NO-related compounds is a critical factor in determining whether indirect (cGMP-dependent) versus direct (cGMP-independent) effects are dominant. However, molecular mechanisms by which different cardiac myocyte types, and associated different ion channel types expressed within them, could achieve selectivity between NO-related indirect versus direct effects are unclear We have previously demonstrated heterogeneous expression gradients of Type III NO synthase (eNOS) and sarcolemmal superoxide dismutase (ECSOD) in ferret and human ventricle, with both enzymes being highly expressed in right ventricle and left ventricular subepicardium but markedly reduced in left ventricular subendocardium. In this study we extend this previous analysis by analyzing NO-activated soluble guanylyl cyclase (sGC) expression in the heart (ferret and human). We demonstrate that, at both tissue and single myocyte levels, sGC protein expression is heterogeneous, being high in sinoatrial node, right atrium, right ventricle and left ventricular subepicardium, but markedly reduced to absent in left atrium and left ventricular subendocardium. Thus, there is a significant overlap in expression gradients of sGC, eNOS, and ECSOD among distinct cardiac tissue and myocyte types. These gradients positively correlate with both: (i) experimentally measured basal NO production levels; and (ii) expression gradients of specific voltage-gated ion channels (particularly Kv1 and Kv4 channels). Our results provide the first demonstration in the heart of an expressed coupled multienzymatic system for selective regulation of indirect (sGC-dependent) versus direct (sGC-independent) NO- and redox-related modulation of voltage-gated ion channel function in different myocyte types. Our results also have functional implications for NO(*)/redox-related modulation of ion channels expressed in other cell types, including neurons, skeletal muscle and smooth muscle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18690042     DOI: 10.4161/chan.5189

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


  5 in total

1.  Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes.

Authors:  Honglan Wang; Mark J Kohr; Christopher J Traynham; Mark T Ziolo
Journal:  J Mol Cell Cardiol       Date:  2009-04-01       Impact factor: 5.000

2.  Phosphodiesterases 3 and 4 Differentially Regulate the Funny Current, If, in Mouse Sinoatrial Node Myocytes.

Authors:  Joshua R St Clair; Eric D Larson; Emily J Sharpe; Zhandi Liao; Catherine Proenza
Journal:  J Cardiovasc Dev Dis       Date:  2017-08-01

3.  Cardioprotective effects of PKG activation by soluble GC activator, BAY 60-2770, in ischemia-reperfusion-injured rat hearts.

Authors:  Kyung Hye Lee; So-Ra Lee; Haneul Cho; Jong Shin Woo; Jung Hee Kang; Yun-Mi Jeong; Xian Wu Cheng; Woo-Shik Kim; Weon Kim
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

4.  Cardiomyocyte depolarization triggers NOS-dependent NO transient after calcium release, reducing the subsequent calcium transient.

Authors:  Matias Mosqueira; Roland Konietzny; Carolin Andresen; Chao Wang; Rainer H A Fink
Journal:  Basic Res Cardiol       Date:  2021-03-17       Impact factor: 17.165

Review 5.  Regional Diversities in Fibrogenesis Weighed as a Key Determinant for Atrial Arrhythmogenesis.

Authors:  Cheng-Chih Chung; Chye-Gen Chin; Yung-Kuo Lin; Yao-Chang Chen; Wan-Li Cheng; Yung-Hsin Yeh; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Biomedicines       Date:  2021-12-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.